Company Ekso Bionics Holdings, Inc.

Equities

EKSO

US2826443010

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 19:32:40 29/04/2024 BST 5-day change 1st Jan Change
1.295 USD +3.60% Intraday chart for Ekso Bionics Holdings, Inc. -0.78% -49.20%

Business Summary

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.

Number of employees: 71

Sales per Business

USD in Million2022Weight2023Weight Delta
EksoHealth
96.8 %
12 91.6 % 18 96.8 % +49.64%
EksoWorks
3.2 %
1 8.4 % 1 3.2 % -46.67%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
68.4 %
7 50.8 % 13 68.4 % +90.64%
Other EMEA
10.3 %
3 22.0 % 2 10.3 % -33.86%
APAC
8.3 %
2 17.5 % 2 8.3 % -32.61%
Poland
7.7 %
-- 1 7.7 % -
Other Americas
2.7 %
0 2.0 % 0 2.7 % +96.43%
Germany
2.6 %
1 7.8 % 0 2.6 % -52.50%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 31/03/21
Director of Finance/CFO 50 30/04/17
Chief Operating Officer 52 -
Investor Relations Contact - -
Human Resources Officer - 31/03/22
Corporate Officer/Principal - 31/12/21
Corporate Officer/Principal - 31/12/19
Sales & Marketing - 31/08/19
Sales & Marketing - -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 57 24/12/21
Director/Board Member 57 28/12/20
Director/Board Member 69 28/12/20
Director/Board Member 39 10/03/18
Chief Executive Officer 54 31/03/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,903,128 15,486,179 ( 86.50 %) 0 86.50 %

Shareholders

NameEquities%Valuation
Hk Takchong International Trading Ltd.
4.159 %
744,572 4.159 % 1 M $
Azimut Capital Management SGR SpA
2.805 %
502,137 2.805 % 682 906 $
Vanguard Group, Inc. (Subfiler)
2.440 %
436,925 2.440 % 594 218 $
364,913 2.038 % 496 282 $
351,873 1.965 % 478 547 $
344,299 1.923 % 468 247 $
331,372 1.851 % 450 666 $
285,840 1.597 % 388 742 $
167,008 0.9328 % 227 131 $
Essex Investment Management Co. LLC
0.8806 %
157,655 0.8806 % 214 411 $

Company contact information

Ekso Bionics Holdings, Inc.

101 Glacier Point Suite A

94901, San Rafael

+510 984 1761

http://www.eksobionics.com
address Ekso Bionics Holdings, Inc.(EKSO)
  1. Stock Market
  2. Equities
  3. EKSO Stock
  4. Company Ekso Bionics Holdings, Inc.